Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Alice Lab
Seoul, South Korea
- Ownership
- Private
- Development stage
- Other
01
Overview
Alice Lab is a South Korean biotechnology company specializing in AI-driven drug discovery. The company utilizes its proprietary platform, ALICE (AI-based Lead Identification and Chemical Evolution), to accelerate the identification and optimization of novel drug candidates. By leveraging deep learning and molecular modeling, Alice Lab focuses on challenging targets such as protein-protein interactions (PPI) to develop innovative therapies, primarily in the field of oncology. The company aims to significantly reduce the time and cost associated with early-stage drug development through its advanced computational capabilities.
- Therapeutic areas
- OncologyMetabolic Disorders
- Modalities
- Small molecule
- Industry
- Biotech
Beyond the preview
Go deeper on Alice Lab.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Alice Lab.